FDA’s Transparency Roadmap: What It Means for Clinical Trial Disclosure
By James Greene Key Takeaways The US Food & Drug Administration (FDA) has put public release of Clinical Study Reports on its agenda. For US sponsors, clinical document…
Topic
Anonymization
TrialAssure Wins “Data Privacy Solution of the Year” for AI-Powered Anonymization and Redaction Platform
CANTON, Mich. – TrialAssure, a leading technology provider advancing clinical trial transparency, disclosure, and data sharing, announced today that its TrialAssure ANONYMIZE product has been named Data Privacy Solution of the Year in…
TrialAssure to Lead Discussions on CCI and Smart Anonymization at PHUSE US Connect 2026 in Austin
AUSTIN, Texas. (February 24, 2026) — TrialAssure, a leading technology provider advancing clinical trial transparency, disclosure, and data sharing, announced today its expanded role at the upcoming PHUSE…
TrialAssure Officially Granted New Patent for Date Offset Anonymization Technology by U.S. Patent and Trademark Office
CANTON, Mich. (December 9, 2025) – TrialAssure, a leading technology provider advancing clinical trial transparency, disclosure, and data sharing, announced today that it has been granted a utility…
Building a Data Sharing Mindset with 5 Steps to Streamline Anonymization Early in Clinical Trials
Anonymization plays a critical role in clinical trial transparency and data sharing in general, but it is often thought of too late in the process. When anonymization planning…
TrialAssure Releases Comprehensive Guide to Anonymization and Redaction Whitepaper for Free Download
Transparency is no longer optional—it’s expected. As regulations around clinical trial disclosures continue to evolve, organizations are under increasing pressure to protect personal and commercially sensitive data while…
EMA’s New Transparency Rules: Don’t Be Caught Late or in Violation
The European Medicines Agency (EMA) has introduced significant updates to its transparency rules, requiring sponsors and CROs to rethink how they manage clinical trial disclosures. These changes, which…
From EudraCT to CTIS: Clinical Trial Sponsors Need to Prepare Anonymization and Redaction Plans Now
The European clinical trials landscape is undergoing a significant transformation with the transition from EudraCT to the Clinical Trials Information System (CTIS). This shift, driven by the European…
The Evolving Challenge of Pinpointing CCI in Clinical Documents
The Informa Clinical Data Disclosure event in Philadelphia this year brought numerous conversations on Company Confidential Information (CCI) to the forefront. For biopharmaceutical companies, protecting proprietary information and…
TrialAssure Launches Anonymize 3.0 Technology for an Improved Data and Document Anonymization User Experience in Pharma and Beyond
CANTON, Mich. (March 14, 2024) – TrialAssure, a leading pharmaceutical technology provider advancing clinical trial disclosure, data sharing, and transparency, announced that its flagship product TrialAssure ANONYMIZE® 3.0…